Frazier Lifesciences Acquisition Co. (NASDAQ:FLAC) Shares Bought by Toronto Dominion Bank

Toronto Dominion Bank raised its holdings in Frazier Lifesciences Acquisition Co. (NASDAQ:FLAC) by 3.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 63,483 shares of the company’s stock after acquiring an additional 2,050 shares during the quarter. Toronto Dominion Bank’s holdings in Frazier Lifesciences Acquisition were worth $624,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Exos Asset Management LLC raised its holdings in Frazier Lifesciences Acquisition by 4.1% during the 3rd quarter. Exos Asset Management LLC now owns 61,481 shares of the company’s stock worth $604,000 after buying an additional 2,420 shares during the period. Citadel Advisors LLC raised its holdings in Frazier Lifesciences Acquisition by 0.8% during the 2nd quarter. Citadel Advisors LLC now owns 554,251 shares of the company’s stock worth $5,409,000 after buying an additional 4,251 shares during the period. Alyeska Investment Group L.P. raised its holdings in Frazier Lifesciences Acquisition by 5.4% during the 2nd quarter. Alyeska Investment Group L.P. now owns 753,492 shares of the company’s stock worth $7,354,000 after buying an additional 38,490 shares during the period. Vivaldi Asset Management LLC raised its holdings in Frazier Lifesciences Acquisition by 88.3% during the 2nd quarter. Vivaldi Asset Management LLC now owns 89,444 shares of the company’s stock worth $873,000 after buying an additional 41,944 shares during the period. Finally, Schonfeld Strategic Advisors LLC raised its holdings in Frazier Lifesciences Acquisition by 85.9% during the 2nd quarter. Schonfeld Strategic Advisors LLC now owns 19,381 shares of the company’s stock worth $189,000 after buying an additional 8,956 shares during the period. Hedge funds and other institutional investors own 39.91% of the company’s stock.

Shares of FLAC opened at $9.80 on Friday. Frazier Lifesciences Acquisition Co. has a fifty-two week low of $9.56 and a fifty-two week high of $12.39. The business’s 50-day moving average is $9.79 and its 200-day moving average is $9.78.

About Frazier Lifesciences Acquisition

Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.

See Also: Trading Stocks – What are percentage gainers?

Want to see what other hedge funds are holding FLAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Frazier Lifesciences Acquisition Co. (NASDAQ:FLAC).

Institutional Ownership by Quarter for Frazier Lifesciences Acquisition (NASDAQ:FLAC)

Receive News & Ratings for Frazier Lifesciences Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Frazier Lifesciences Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.